Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04245722 |
| Title | FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Fate Therapeutics |
| Indications | |
| Therapies |
Cyclophosphamide + Fludarabine + FT596 + Obinutuzumab |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The University of Chicago | Recruiting | Chicago | Illinois | 60637 | United States | Details |
| University of Minnesota Masonic Cancer Center | Recruiting | Minneapolis | Minnesota | 55455 | United States | Details |
| Washington University School of Medicine | Recruiting | Saint Louis | Missouri | 63110 | United States | Details |
| NYU Langone Health | Recruiting | New York | New York | 10016 | United States | Details |
| Memorial Sloan Kettering Cancer Center | Recruiting | New York | New York | 10065 | United States | Details |
| Sarah Cannon Research Institute (Tennessee Oncology) | Recruiting | Nashville | Tennessee | 37203 | United States | Details |
| MD Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States | Details |
| SCRI-TTI | Recruiting | San Antonio | Texas | 78229 | United States | Details |
| Swedish Cancer Institute | Recruiting | Seattle | Washington | 98104 | United States | Details |